Literature DB >> 6459665

Measurement of serum and tissue concentration of moxalactam using high pressure liquid chromatography.

W F Diven, B D Obermeyer, R L Wolen, V L Yu, J Lyon, J Zuravleff.   

Abstract

We describe a sensitive high pressure liquid chromatographic (HPLC) procedure for the analysis of the new beta-lactam antibiotic moxalactam. Conditions are described for either measurement of total drug concentration or the concentration of the individual isomers. The proteins in a 1.0 ml plasma sample are denatured with isopropyl alcohol which is then extracted into a chloroform reagent, leaving the drug in the aqueous phase. An aliquot is then injected into a mu-bondapak phenyl column. A similar extraction procedure was employed for tissue homogenates. Linear regression analysis and comparison of the HPLC assay with the microbiological assay gave a correlation coefficient of 0.97. Analysis of tissue samples indicated that significant concentrations of moxalactam were obtained at the site of infection.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6459665     DOI: 10.1097/00007691-198103000-00011

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  7 in total

1.  Determination of cefoperazone concentration in serum and muscle tissue with a versatile high-pressure liquid chromatographic method.

Authors:  R R Muder; W F Diven; V L Yu; J Johnson
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

2.  Moxalactam kinetics during continuous ambulatory peritoneal dialysis after intraperitoneal administration.

Authors:  T E Jones; R W Milne; Y Mudaliar; L N Sansom
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

3.  Pharmacokinetics of intravenous and intraperitoneal moxalactam in chronic ambulatory peritoneal dialysis.

Authors:  H Albin; J M Ragnaud; F Demotes-Mainard; G Vincon; C Wone
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

4.  High performance liquid chromatographic determination of moxalactam in human plasma and cerebrospinal fluid.

Authors:  J Nielsen; G Karlaganis; H M von Hattingberg; U B Schaad
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

5.  Penetration of moxalactam and cefazolin into atrial appendage after simultaneous intramuscular or intravenous administration.

Authors:  R E Polk; J E Smith; K Ducey; R R Lower
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

6.  Peritoneal absorption of moxalactam.

Authors:  N M Stephens; N O Kronfol; B J Kline; R E Polk
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

Review 7.  Clinical pharmacokinetics of the third generation cephalosporins.

Authors:  L Balant; P Dayer; R Auckenthaler
Journal:  Clin Pharmacokinet       Date:  1985 Mar-Apr       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.